BioPlus Acquisition Total Liabilities

BioPlus Acquisition (BIOS) currently reports a total liabilities of $17M as of June 2023. That compares with $15M in the prior-year period — up 11.6% year over year. Use the charts on this page to explore BioPlus Acquisition's total liabilities history and peer comparisons.

BioPlus Acquisition's total liabilities increased from $15M to $17M — a 11.6% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioPlus Acquisition reported $17M in total liabilities as of June 2023. That compares with $15M in the prior-year period — up 11.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $17M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioPlus Acquisition, and consider following BIOS for alerts when major investors trade the stock.